Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I3VT
|
||||
Former ID |
DIB012104
|
||||
Drug Name |
CAD-106
|
||||
Synonyms |
Amilomotide; Alzheimers disease vaccine, Cytos/Novartis; Immunodrug vaccines (Alzheimers disease), Cytos/Novartis; Beta amyloid 1-6 peptide/Qbeta virus-like particle conjugate (Alzheimer's disease), Cytos/Novartis
|
||||
Drug Type |
Vaccine
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 2/3 | [525332] | ||
Company |
Cytos Biotechnology AG
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | [531529] | ||
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.